Anika Therapeutics, Inc. (ANIK) Capital expenditures 2016–2025
Anika Therapeutics, Inc. (ANIK) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$6.8MFY2025 · since FY2016: $14.0M → $6.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6.8M | -11.7% |
| FY2024 | $7.7M | +42.5% |
| FY2023 | $5.4M | -27.5% |
| FY2022 | $7.5M | +45.6% |
| FY2021 | $5.1M | +215.9% |
| FY2020 | $1.6M | -42.4% |
| FY2019 | $2.8M | -39.3% |
| FY2018 | $4.7M | -48.2% |
| FY2017 | $9.0M | -35.9% |
| FY2016 | $14.0M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice